Sp627
NECESSITY IS THE MOTHER OF INVENTION: HOW THE PANDEMIC HAS CHANGED OUR PARADIGMS FOR PATIENT CARE
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinical and research practices; and 3) to examine structural barriers in the field of gastroenterology during the pandemic and effective advocacy strategies.
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinical and research practices; and 3) to examine structural barriers in the field of gastroenterology during the pandemic and effective advocacy strategies.
Presenter
University of Michigan Michigan Medicine
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Q&A
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinica…
